Support & Resources
Support & Resources

Pfizer Oncology Together can help you understand your options for how to obtain your prescribed VIZIMPRO. We can identify a specialty pharmacy that can fill your prescription, based on your insurance plan. Specialty pharmacies provide medicines that might not be available at typical neighborhood pharmacies. Usually a specialty pharmacy will ship your medicine directly to your home.

Back to top

Financial assistance

Finding financial support options. Together.

Pfizer Oncology Together can help you understand your insurance and identify what financial support may be available for your prescribed VIZIMPRO. In addition, we can help find a specialty pharmacy that can fill your prescription.

Commercially Insured

Co-Pay Assistance

Eligible, commercially insured patients may pay as little as $0 per month for VIZIMPRO. Limits, terms, and conditions apply*

*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 in savings per product annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For any questions, please call 1-877-744-5675, visit or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

Medicare/Government Insured

Help identifying resources for eligible patients with Medicare/Medicare Part D, Medicaid, and other government insurance plans:

4-0-1_icons1.jpg Assistance with searching for financial support that may be available from independent charitable foundations. These foundations exist independently of Pfizer and have their own eligibility criteria and application processes. Availability of support from the foundations is determined solely by the foundations

4-0-1_icons2.jpg Financial assistance through Extra Help, a Medicare Part D Low-Income Subsidy (LIS) program 

4-0-1_icons3.jpg Free medicine†

†If support from independent charitable foundations or Medicare Extra Help is not available, Pfizer Oncology Together will provide eligible patients with medication for free through the Pfizer Patient Assistance Program. The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance FoundationTM. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.


Help identifying resources for eligible patients without any form of healthcare coverage:

4-0-1_icons2_0.jpgHelp finding coverage

4-0-1_icons3_0.jpg Free medicine through the Pfizer Patient Assistance Program, or at a savings through the Pfizer Savings Program‡

‡The Pfizer Savings Program is not health insurance. For more information, call the toll-free number 1-877-744-5675. There are no membership fees to participate in this program. Estimated savings are 50% and depend on such factors as the particular drug purchased, amount purchased, and the pharmacy where purchased.

Back to top

Personalized support

Care Champion Support

At Pfizer Oncology Together, our Care Champions, who have social work experience, can provide you resources that may help with some of your day-to-day challenges§:

Emotional Support

  • Connections to emotional support resources such as diagnosis-specific support groups, an independent organization’s helpline, and a free app to connect with loved ones

Educational Support

  • Educational information about physical and mental health, nutrition, and VIZIMPRO

Practical Support

  • Connections to independent organizations that help eligible patients find free rides and lodging for treatment-related appointments
  • Information to help you prepare for leaving or returning to work

§Some services are provided through third-party organizations that operate independently and are not controlled by Pfizer. Availability of services and eligibility requirements are determined solely by these organizations.

For Live, Personalized Support
Call 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET)
or visit

Request a call

Additional Support

LUNGevity Foundation
LUNGevity Foundation

LUNGevity Foundation, the nation’s leading lung cancer organization, is committed to increasing quality of life and survivorship of all people with lung cancer. We accelerate lifesaving, translational research into early detection and more effective treatments, provide trusted educational tools to empower patients and their caregivers, promote effective public policy initiatives, develop models for improved access to the best healthcare for all, including underserved populations, and amplify the patient voice through research and engagement.
GO2 Foundation for Lung Cancer

GO2 Foundation for Lung Cancer

Founded by patients and survivors, GO2 Foundation for Lung Cancer transforms survivorship as the world’s leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. They work to change the reality of living with lung cancer by ending stigma, increasing public and private research funding, and ensuring access to care.
Lung Cancer Research Foundation
Lung Cancer Research Foundation

The Lung Cancer Research Foundation is dedicated to improving lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. In addition, the organization offers awareness and educational programs and brings the lung cancer community together through Free to Breathe Walks and other events nationwide.
For more information, visit

These websites are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of these sites.

Back to top

Downloadable materials

Download and print these useful documents. They’ll help educate you about NSCLC and VIZIMPRO as well as prepare you for what to expect while taking VIZIMPRO.


Getting Started With VIZIMPRO Patient Brochure

Includes information about VIZIMPRO to help you understand how it works, findings from a clinical trial, and what you may expect
View Full Prescribing Information


What to Expect With VIZIMPRO Guide

Gives a more detailed look at the most common side effects associated with VIZIMPRO 
View Full Prescribing Information

Back to top

Important Safety Information and Indication

Important Safety Information and Indication

VIZIMPRO may cause serious side effects, including:

  • Lung or breathing problems. VIZIMPRO may cause severe inflammation of the lung that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you have any new or worsening lung symptoms, including trouble breathing or shortness of breath, cough, or fever.
  • Diarrhea. Diarrhea is common during treatment with VIZIMPRO, and can be severe and lead to death. Diarrhea can cause you to lose too much body fluid (dehydration). Your healthcare provider may tell you to start drinking more fluids or start taking your anti-diarrheal medicines. Tell your healthcare provider right away, if you have any loose stools or have stools more often than is normal for you.
  • Skin reactions. Skin reactions are common with VIZIMPRO and can be severe. These skin reactions may include: dry skin, redness, rash, acne, itching, and peeling or blistering of your skin. Use moisturizers every day when taking VIZIMPRO. Use sunscreen and wear protective clothing that covers your skin, while exposed to sunlight, while you are taking VIZIMPRO. Your healthcare provider may prescribe other medicines to help skin reactions. Tell your healthcare provider right away about any worsening skin reactions.

Before taking VIZIMPRO, tell your healthcare provider about all your medical conditions, including if you:

  • have frequent diarrhea.
  • have a history of lung or breathing problems other than lung cancer.
  • are pregnant, or plan to become pregnant. VIZIMPRO can harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider should do a pregnancy test before you start treatment with VIZIMPRO.
  • You should use effective birth control (contraception) during treatment and for at least 17 days after your last dose of VIZIMPRO. Talk to your healthcare provider about birth control methods that may be right for you during this time.
  • Tell your healthcare provider right away if you become pregnant during your treatment with VIZIMPRO.
  • are breastfeeding or plan to breastfeed. It is not known if VIZIMPRO passes into your breast milk. Do not breastfeed during treatment and for at least 17 days after your last dose of VIZIMPRO. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIZIMPRO and other medicines or supplements may affect each other causing side effects.

What should I avoid during treatment with VIZIMPRO?

Minimize exposure to sunlight. VIZIMPRO can cause skin reactions.

The most common side effects of VIZIMPRO include:

  • rash
  • diarrhea
  • mouth pain and sores
  • nail inflammation
  • common cold
  • dry skin
  • decreased appetite
  • decreased weight
  • dry, red, itchy eyes
  • hair loss
  • itching

These are not all of the possible side effects of VIZIMPRO. You can ask your pharmacist or healthcare provider for more information about VIZIMPRO that is written for health professionals.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Indication: VIZIMPRO is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic).

  • VIZIMPRO is used as a first treatment if tumors have certain types of abnormal epidermal growth factor receptor (EGFR) gene(s).

Your healthcare provider will perform a test to make sure that VIZIMPRO is right for you. It is not known if VIZIMPRO is safe and effective in children.

Please see Full Prescribing Information and Patient Information.

Scroll for Important Safety Information and Indication